Showing results (161-170 of 555) with videos related to
Sort By:
Pageof 56
Journal of Neural Transmission. Supplementum|January 1, 1995
Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?D Blum-Degen, L Frölich, S Hoyer, et al.Journal of Neural Transmission. Supplementum|January 1, 1996
New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegilineM Gerlach, H Desser, M B Youdim, et al.Journal of Neural Transmission. Supplementum|January 1, 1995
Dopaminergic effects on cognitive performance in patients with Parkinson's diseaseK W Lange, G M Paul, M Naumann, et al.Journal of Neural Transmission. Supplementum|January 1, 1994
MPTP-induced degeneration: interference with glutamatergic toxicityP A Löschmann, K W Lange, H Wachtel, et al.Experimental Neurology|August 1, 1986
Neuronal plasticity in the nigrostriatal system of the rat after unilateral removal of vibrissaeJ P Huston, S Morgan, K W Lange, et al.Acta Psychiatrica Scandinavica|December 1, 1988
Platelet MAO-B activity and the psychopathology of Parkinson's disease, senile dementia and multi-infarct dementiaW Danielczyk, M Streifler, C Konradi, et al.Neurobiology of Disease|October 11, 2001
The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer's disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer's disease?I Schnurra, H G Bernstein, P Riederer, et al.Acta Neuropathologica|July 21, 1999
The N-methyl-D-aspartate receptor channel blocker amantadine does not cause histopathological alterations in human brain tissueJ Kornhuber, K Jellinger, J Wiltfang, et al.Journal of Neural Transmission. Supplementum|December 16, 1998
Free radicals in Alzheimer's diseaseW Retz, W Gsell, G Münch, et al.Der Nervenarzt|October 1, 1988
[Schizophrenic psychosis in a patient with Gilles de la Tourette syndrome]T Becker, G Laux, E Sofic, et al.Pageof 56